The initiation of #tirzepatide therapy significantly decreases the incidence of myocardial infarction and all-cause mortality among high-risk individuals with type 2 #diabetes.
www.endocrinologyadvisor.com/news/t…
endocrinologyadvisor.com
Tirzepatide Reduces Cardiovascular Events in Type 2 Diabetes
Tirzepatide therapy reduces the risk for major adverse cardiovascular events in patients with type 2 diabetes and established CVD.